Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
NCT00002715 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00002715 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma |
| Official title | A Phase II Pilot Study of Short Term (12 Week) Combination Chemotherapy (Stanford V) in Unfavorable Hodgkin's Disease |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | Bleomycin sulfate, Stanford V regimen, Doxorubicin hydrochloride, Etoposide, Mechlorethamine hydrochloride, Prednisone, Vinblastine, Vincristine sulfate |
| Enrollment | 50 |
| Start date | Apr 1, 1989 |
| Primary completion | Jan 1, 2007 |
| Completion | Oct 1, 2015 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 12, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: